This ancillary study utilized data from a multicenter , prospective , randomized , parallel-group study conducted in subjects with moderate RA randomized to receive etanercept and methotrexate ( ETN + MTX ) or usual care ( various disease-modifying antirheumatic drugs [ DMARDs ] ) .
